Arno Therapeutics, Inc. (ARNI)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Jan 30, 2026
Arno Therapeutics Market Cap
Arno Therapeutics has a market cap or net worth of $49 as of February 12, 2026. Its market cap has decreased by -99.95% in one year.
Market Cap
49.00
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since June 11, 2008, Arno Therapeutics's market cap has decreased from 40.78M to 49.00, a decrease of -100.00%. That is a compound annual growth rate of -53.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 49.00 | -99.50% |
| Dec 12, 2025 | 9.87K | 20,042.86% |
| Dec 30, 2022 | 49.00 | -99.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RenovaCare | 87.00 |
| Cardax | 83.00 |
| Bioasis Technologies | 79.00 |
| Gelesis Holdings | 73.00 |
| Athersys | 62.00 |
| Genocea Biosciences | 59.00 |
| Panacos Pharmaceuticals | 54.00 |
| Baudax Bio | 52.00 |